1.Previous
3.Next

drugs fail in Phase 2 clinical trials due to the drug not being as effective as anticipated.
* Phase 3: The drug is typically tested in several hundred to several thousand people with the targeted disease in double-blind, placebo controlled trials to demonstrate its specific efficacy. Under 30% of drug candidates succeed through Phase 3.
* Phase 4: These are postmarketing surveillance trials in several thousand

1.Previous
3.Next